GPhA Hires Prominent Lobbyist Melissa A. Schulman to Lead Government Affairs Team

GPhA Hires Prominent Lobbyist Melissa A. Schulman to Lead Government Affairs Team


GPhA announced today that it has hired Melissa A. Schulman as Senior Vice President, Government Affairs. Schulman, one of the best known advocates in Washington, comes to GPhA from the Bockorny Group, where she was a principal and the senior Democratic lobbyist.

"The GPhA team is exceptionally pleased that Melissa is joining us," said Ralph G. Neas, President and CEO of GPhA. "She brings a well-earned reputation for ensuring that her client's voice is heard. In addition, Melissa's combination of 15 years of private sector experience and 14 years working in Congress makes her a perfect choice to lead our Association's advocacy efforts. There is no doubt that our member companies, who are responsible for 80% of the prescriptions in the U.S., provide a fundamental service to the health system and to American consumers. Adding Melissa to our team will immeasurably strengthen our efforts to represent their interests in the halls of Congress and across the country. "

Schulman is best known for her deep relationships across Capitol Hill, especially with moderate members, and her ability to articulate to Congress the complex needs of heavily regulated industries. She has consistently been ranked as one of the most influential voices in Washington by Roll Call, The Hill, National Journal, and others.

"There couldn't be a more exciting time to work for GPhA," said Schulman. "At a time when the budget is front and center in every legislative debate, the generics industry has proven it can be an invaluable partner to legislators to find practical solutions to the difficult problem of rising health care costs. I am looking forward to being part of that dialogue."

Before joining the Bockorny Group, Schulman served as Executive Director of the Democratic Caucus and Policy Director to Representative Steny Hoyer. As a legislative assistant in Congressman Hoyer's office, Schulman helped to steer the Americans with Disabilities Act through its consideration in the House of Representatives. Prior to her tenure in Representative Hoyer's office, Schulman worked with Representatives Thomas Manton (D-NY) and Geraldine Ferraro (D-NY).

GPhA represents the manufacturers and distributors of finished generic pharmaceuticals, manufacturers and distributors of bulk pharmaceutical chemicals, and suppliers of other goods and services to the generic industry. Generic pharmaceuticals fill 80 percent of the prescriptions dispensed in the U.S. but consume just 27 percent of the total drug spending. Additional information is available at

Suggested Articles

Joe Jimenez has (another) new gig. The ex-Novartis boss joined the board of Century Therapeutics, a startup working on off-the-shelf cell therapies.

As Pfizer posts its full-year financials today, as usual it’s also sneaked in several dropped projects from its pipeline.

The short seller thinks Principia’s approach to the treatment of autoimmune diseases is “misguided” and likely to lead to clinical failures.